Connect with us
Sunday,02-October-2022
Breaking News

Business

Covaxin jab may hamper your travel plans abroad

Published

on

Covaxin

As several countries get ready to reopen their borders for vaccinated foreign travellers, Indians who have received Bharat Biotech’s Covid-19 vaccine Covaxin jabs may not qualify for travelling abroad as many countries are yet to approve the vaccine.

Multiple reports said that over 130 countries across the globe currently accept Serum Institute of India’s (SII) Covishield vaccine to enter their country while Covaxin is accepted in only nine nations.

Also, Covaxin is not yet on the World Health Organisation’s (WHO) Emergency Use Listing (EUL).

The latest WHO guidance document shows that Bharat Biotech has submitted its Expression of Interest (EoI) but “more information is required”.

Bharat Biotech was yet to react to the reports.

However, a peer-review publication Clinical Infectious Diseases has noted that Covaxin demonstrates protection against the new Covid-19 variants.

The study found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.

A modest reduction in neutralisation by a factor of 1.95 was observed against the B1617 variant compared to the vaccine variant.

Top officials in the country said this week that they will begin clinical trials to test the Covaxin vaccine’s efficacy in children between two to 18 years of age in 10-12 days.

“Covaxin has been approved by the Drugs Controller General of India (DCGI) for Phase 2 and 3 clinical trials in the age group of two to 18 years. I have been told that trials will begin in the next 10-12 days,” V.K. Paul, NITI Aayog’s Member Health, had said.

Business

Airtel showcases 5G ambulance, smart agri 5G solutions to PM Modi

Published

on

By

 Bharti Airtel on Saturday showcased a 5G-connected ambulance to transform primary health care in emergency situations, along with smart farming solutions to Prime Minister Narendra Modi at the 5G official launch in the country.

The 5G ambulance, that can be built for around Rs 7-7.5 lakh, brings a hospital’s emergency care to the patient.

Airtel, Apollo Hospitals and Cisco have joined hands to build the 5G-connected ambulance.

The state-of-the-art 5G ambulance is equipped with the latest medical equipment, patient monitoring applications, and telemetry devices that transmit the patient health data to the hospital in real-time.

In addition, it is also equipped with onboard cameras, camera-based Headgear, and ‘Bodyc Cams’ for paramedic staff — all connected to the ultra-fast and low latency Airtel 5G network.

It will be further enabled with technologies like AR/VR, said the company.

“Healthcare is one of the most promising use cases for 5G, and we are delighted to deepen our partnerships with Apollo Hospitals and Cisco to bring some innovative use cases for the Indian market,” said Ajay Chitkara, Director & CEO, Airtel Business, Bharti Airtel.

With real-time camera feed available, the paramedics in an ambulance can use the cameras to collaborate with the ER doctors at the hospital who are equipped with technologies like AV/VR to undertake basic procedures, if necessary.

The doctors can virtually guide the paramedic to carry out the procedure and save precious lives.

The Airtel’s ‘Ambupod’ technology provides health testing, immunisation and the doctor’s connectivity in difficult-to-reach areas.

“Doctors can do a virtual examination of the patient through a video call and view their reports. Medical services can be provided to many villages at the same time,” according to the telecom provider.

The company also showcased smart farming solutions to Modi during his visit to the Airtel pavilion.

Airtel, along with its partners L&T and CDAC, has made an effort to make the agriculture sector more productive with the help of 5G technology.

“If every farmer in the country gets the necessary information like soil moisture, atmospheric moisture and temperature information in advance to improve the productivity of agriculture, then he can make a better decision,” the company said.

Camera-based analytics can suggest to the farmer according to the colour and nature of the crop, at what time and how much pesticide to use.

Continue Reading

Business

Vi to introduce 5G mobile cloud gaming service in India

Published

on

By

Telecom operator Vi (Vodafone Idea) on Friday announced its partnership with gaming platform CareGame to offer 5G Cloud gaming experience to its users in India.

The company said that with 5G’s low latency technology, the cloud gaming industry is expected to democratise even further.

“The online gaming industry is among the fastest growing entertainment segments in India and with the advent of 5G it is expected to grow many folds. Mobile gaming is a key agenda for us to drive engagement with our consumers”, Avneesh Khosla, Chief Marketing Officer, Vodafone Idea, said in a statement.

As per a report by Boston Consulting Group (BCG), India currently has a user base of 300 million mobile gamers. Growing at a CAGR of 38 per cent, the Indian mobile gaming industry is expected to triple in size to a $5 billion market by 2025.

“Our unique Mobile Cloud Gaming technology lifts all these barriers up so that all mobile gamers can enjoy all these great mobile games, whether being RPG, MOBA, Battle Royale, Strategy, Simulation, FPS, Racing or in any other genre”, said Benjamin Athuil, Co-founder and President of CareGame.

The company will showcase the service at the India Mobile Congress (IMC), being held from October 1-4 at Pragati Maidan in New Delhi.

Continue Reading

Business

JioPhone 5G price leak stirs controversy, research firm clarifies

Published

on

By

Leading market research firm Counterpoint Research has refuted certain reports that used its findings to convey that Reliance Jio is set to launch the 5G version of its JioPhone Next affordable smartphone around Rs 8,000-Rs 12,000.

In a clarification posted on Twitter, Counterpoint said that “some comments from our research note dated 26th September 2022 on the JioPhone Next BoM have been taken out of context”.

“This is leading to misquotes and misrepresentations of our intent. In our research, we speculate about the possible pricing of a 5G phone from Jio, but we have no specific knowledge of any possible or exact pricing plans for 5G products or the potential timing of any 5G products from Jio,” said the research agency.

In its report, the industry report touched upon the JioPhone Next 4G, saying it is a unique smartphone for its price segment, retailing at around $55-$80 (Rs 4,400-Rs 6,400) depending on the seasonal/regional/buyback offers, supported by a compact design.

“The device rounds up Jio’s strategy well — first, to use the JioPhone Next 4G to attract hundreds of millions of 2G feature phone users to its 4G network and second, to aim to deliver a $100 to $150 (Rs 8,000-Rs 12,000) affordable 5G smartphone once the coverage has reached a good threshold to attract the mass-market 4G smartphone users to its 5G network,” the bill of materials (BoM) analysis said.

“This two-pronged strategy will be the key to Jio’s growth and extend its leadership to the 5G era as well,” it added.

Further, at some point in 2024, Jio will also be compelled to launch an affordable 5G mmWave + Sub-6 GHz smartphone as the cost deltas between the two would have narrowed significantly from the BoM perspective.

Continue Reading

Trending